|
FDA continues strong support of innovation in development of gene therapy products
|
29 January 2020 |
|
FDA approves first treatment option specifically for patients with epithelioid sarcoma
|
24 January 2020 |
|
FDA approves first treatment for thyroid eye disease
|
21 January 2020 |
|
FDA approves the first targeted therapy to treat a rare mutation in patients with gastrointestinal stromal tumors
|
10 January 2020 |
|
FDA approves new treatment for adults with migraine
|
01 January 2020 |
|
FDA approves first generics of Eliquis
|
26 December 2019 |
|
FDA approves new treatment option for patients with HER2-positive breast cancer who have progressed on available therapies
|
20 December 2019 |
|
FDA approves new type of therapy to treat advanced urothelial cancer
|
19 December 2019 |
|
FDA grants accelerated approval to first targeted treatment for rare Duchenne muscular dystrophy mutation
|
13 December 2019 |
|
FDA launches app for health care professionals
|
09 December 2019 |
|
FDA approves first generics of Gilenya
|
05 December 2019 |
|
FDA approves novel treatment to target abnormality in sickle cell disease
|
25 November 2019 |
|
FDA approves first treatment for inherited rare disease
|
20 November 2019 |
|
FDA approves first targeted therapy to treat patients with painful complication of sickle cell disease
|
15 November 2019 |
|
FDA approves first therapy to treat patients with rare blood disorder
|
08 November 2019 |
|
Digital submission of adverse event reports for investigational new drug applications
|
29 October 2019 |
|
FDA approves new treatment for patients with migraine
|
11 October 2019 |
|
FDA awards 12 grants to fund new clinical trials to advance the development of medical products for the treatment of rare diseases
|
08 October 2019 |
|
FDA approves second drug to prevent HIV infection as part of ongoing efforts to end the HIV epidemic
|
03 October 2019 |
|
FDA announces voluntary recall of Sandoz ranitidine capsules following detection of an impurity
|
24 September 2019 |